Skip to main content
. 2018 Apr 18;2018:8926598. doi: 10.1155/2018/8926598

Table 2.

Overall response rate.

Best overall response No. (%)
Complete response 3 (4)
Partial response 12 (16)
Overall response 15 (20)
Stable disease 31 (41)
Progressive disease 27 (36)
Not evaluable or not assessed 2 (3)